Early Insights Into Home OCT Monitoring Reveal Real-World Impact - Takeaways - MDSpire

Early Insights Into Home OCT Monitoring Reveal Real-World Impact

  • By

  • Jim Gallagher, senior managing editor

  • January 1, 2026

  • 6 min

Share

  • 1

    Home OCT monitoring for neovascular age-related macular degeneration offers reduced patient burden and continuous data collection.

  • 2

    The FDA approved the Scanly home OCT device in May 2024, enabling patients to perform scans at home.

  • 3

    Patients reported high satisfaction with the home OCT device, finding it user-friendly and reassuring.

  • 4

    The Wagner Kapoor Institute utilized its research wing to effectively implement the home OCT program.

  • 5

    Remote monitoring can enhance patient care, especially in rural areas, by detecting changes before symptoms arise.

Original Source(s)

Related Content